Jazz Pharmaceuticals PLC
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +157.5% | +64.7% | +13.6% | +43.1% | +31.1% | +11.0% | +17.4% | +15.3% | -2.8% | +15.9% | -13.5% | +63.4% | -14.1% | +27.8% | -2.9% | |
| – | +89.6% | +2.1% | +42.8% | -39.5% | -4.2% | -10.1% | +848.4% | +10.6% | +62.8% | -19.2% | +5.3% | +45.2% | +31.2% | +70.8% | -24.8% | +98.6% | +13.9% | +1.5% | +3.3% | +5.5% | |
| – | – | – | +33.8% | -26.5% | +38.0% | +151.9% | +11.1% | +93.6% | +56.3% | +31.5% | +7.9% | +8.2% | -4.2% | +7.9% | +9.4% | +56.2% | +17.5% | +2.2% | +9.3% | +17.4% | |
| – | – | – | – | – | – | – | -696.2% | – | +9.1% | -10.4% | -7.9% | -281.2% | – | -114.1% | – | +288.9% | -77.0% | – | – | – | |
| – | +440.5% | +78.6% | -92.4% | -1,247.0% | – | – | – | – | – | – | – | – | -13.0% | -744.5% | – | – | – | -2,164.0% | – | – | |
| – | +19.0% | +87.2% | +812.6% | -78.9% | -21.8% | +22.2% | +288.9% | -49.8% | +2,019.3% | -85.0% | +405.0% | -37.2% | +15.4% | +38.7% | +108.0% | -88.0% | +994.2% | -95.2% | +100.6% | +336.3% | |
| – | -99.0% | – | -323.8% | -48.7% | -65.0% | +3,690.6% | +386.6% | -97.1% | +9,368.3% | -99.8% | +77,474.3% | -84.6% | +46.7% | -60.6% | +548.9% | +417.2% | -91.4% | -63.5% | +211.7% | +197.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +72.4% | 0.0% | -1.6% | – | – | – | |
| – | – | – | -93.5% | +0.0% | +875.0% | -73.7% | -254.3% | +439.5% | -69.1% | +45.8% | +352.1% | -64.5% | +430.0% | -42.4% | -51.4% | -75.7% | -99.8% | +499,457.4% | +15.4% | -59.9% | |
| – | – | – | – | – | – | – | – | -80.1% | +911.1% | -118.9% | – | -140.0% | -90.2% | +3.9% | – | +554.1% | -115.0% | -94.7% | – | -308.4% | |
| – | -39.2% | -14.9% | -35.7% | -80.2% | -316.8% | +20.2% | – | -105.4% | – | -130.1% | – | -175.6% | +17.1% | -38.7% | – | +651.9% | -113.3% | -42.3% | – | -4,357.1% | |
| – | – | -58.9% | -425.2% | – | – | +27.7% | +718.4% | -18.3% | -80.9% | +541.1% | -304.4% | – | -480.7% | – | +28.3% | -210.9% | – | +115.4% | +45.1% | -212.6% | |
| – | – | – | – | – | – | +169.3% | +55.9% | +19.8% | -38.8% | +197.4% | -17.5% | +41.6% | +15.2% | -11.0% | -12.4% | +40.9% | +5.6% | +38.0% | +26.2% | -15.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.